Christina Thirlwell

Christina Thirlwell

Huntley Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs).

Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs).

Journal: ESMO gastrointestinal oncology
Published: February 06, 2026

Correction to: Molecular Subtypes of Pancreatic Neuroendocrine Tumors Mutated in MEN1/DAXX/ATRX Explain Biological Variability.

Correction to: Molecular Subtypes of Pancreatic Neuroendocrine Tumors Mutated in MEN1/DAXX/ATRX Explain Biological Variability.

Journal: Endocrine pathology
Published: November 25, 2025

Molecular Subtypes of Pancreatic Neuroendocrine Tumors Mutated in MEN1/DAXX/ATRX Explain Biological Variability.

Molecular Subtypes of Pancreatic Neuroendocrine Tumors Mutated in MEN1/DAXX/ATRX Explain Biological Variability.

Journal: Endocrine pathology
Published: March 13, 2025

Clinical and Genetic Factors Associated with Neuroendocrine Neoplasms: A UK Biobank Study.

Clinical and Genetic Factors Associated with Neuroendocrine Neoplasms: A UK Biobank Study.

Journal: Neuroendocrinology
Published: December 04, 2024

European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours.

European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours.

Journal: Journal of neuroendocrinology
Published: April 25, 2024

Colorectal cancer risk stratification using a polygenic risk score in symptomatic primary care patients-a UK Biobank retrospective cohort study.

Colorectal cancer risk stratification using a polygenic risk score in symptomatic primary care patients-a UK Biobank retrospective cohort study.

Journal: European journal of human genetics : EJHG
Published: December 13, 2023

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.

Journal: Journal of neuroendocrinology
Published: May 03, 2023

A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires.

A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires.

Journal: Journal of clinical medicine
Published: January 22, 2022

Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms.

Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms.

Journal: Endocrine-related cancer
Published: June 29, 2021

High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis.

High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis.

Journal: Pancreas
Published: May 03, 2021

Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 Patients.

Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 Patients.

Journal: Neuroendocrinology
Published: May 31, 2020

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.

Journal: Nature communications
Published: January 09, 2020
Showing 1-12 of 42

Last Updated: 09/26/2026